Riskpilot← Back to searchSign inGet full accessKLÆBU LEGESENTER AS
ASActiveOrg 993075973Tine Bugges Veg 1A, 7540 KlæbuGeneral medical practice activities · NACE 8621Est. 20087 employees
Revenue 2025
NOK 4,7M
-2% vs 2024
EBITDA margin
1.0%
+76% vs 2024
Equity ratio
35.2%
Financial strength
Net profit 2025
NOK 14K
+438% vs 2024
| Revenue | NOK 4,7M | -2% |
| EBITDA | NOK 47K | +76% |
| Net profit | NOK 14K | +438% |
| Total assets | NOK 1,1M | -7% |
| Equity | NOK 376K | +4% |
| Employees | 7 | — |
Legal name
KLÆBU LEGESENTER AS
Org number
993075973
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. september 2008
Share capital
NOK 125 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Helsetjenester, informasjon, salg samt deltagelse i selskaper av samme eller annen art gjennom aksjetegning eller på annen måte.
Address
Tine Bugges Veg 1A, 7540 Klæbu
Phone
+4772830170
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 018 | 4 007 | 4 221 | 4 774 | 4 674 |
| Staff expenses | −1 987 | −2 156 | −2 201 | −2 350 | −2 373 |
| EBITDA | 73 | 234 | 6 | 27 | 47 |
| Depreciation & amort. | −58 | −58 | −62 | −24 | −30 |
| EBIT | 16 | 177 | −55 | 2 | 17 |
| Net financials | −0 | −0 | 1 | 1 | −0 |
| Profit before tax | 16 | 176 | −54 | 3 | 17 |
| Tax | 3 | 39 | −12 | 1 | 4 |
| Net profit | 13 | 137 | −42 | 3 | 14 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 799 | 1 168 | 977 | 1 143 | 1 069 |
| Equity | 265 | 402 | 360 | 362 | 376 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 535 | 766 | 617 | 781 | 693 |
| Total debt | 535 | 766 | 617 | 781 | 693 |
EBITDA margin
1.0%
This company
15.8%
Market median
-94% vs market
20212025
Equity ratio
35.2%
This company
38.2%
Market median
+8% vs market
20212025
Return on equity
3.6%
This company
18.4%
Market median
-80% vs market
20212025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20212025
Asset turnover
4.37×
This company
1.12×
Market median
+290% vs market
20212025
Debt / equity
1.84×
This company
0.62×
Market median
-197% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairman | 2018 – 2022 | |
| Board of Directors | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLÆBU LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rahele Zarabi | Chairman | 0 companies |
| Susanna Bruheim | Board of Directors | 0 companies |